Dimitris Voliotis

Corporate Officer/Principal presso ZENTALIS PHARMACEUTICALS, INC.

61 anni

Health Technology

Consumer Services

Posizioni attive di Dimitris Voliotis

Società	Posizione	Inizio	Fine
ZENTALIS PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/03/2020	-

Società	Posizione	Inizio	Fine
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Corporate Officer/Principal	01/01/2019	01/02/2020
Eisai, Inc. Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ.	Corporate Officer/Principal	01/09/2014	01/01/2019
Bayer HealthCare AG Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.	Corporate Officer/Principal	01/01/2001	01/09/2014

Universität zu Köln

Doctorate Degree

Distribuzione geografica

Germania	4
Stati Uniti	3

Posizioni

Corporate Officer/Principal	4
Doctorate Degree	1

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ZENTALIS PHARMACEUTICALS, INC.	Health Technology

Aziende private	3
CureVac SE CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.	Health Technology
Eisai, Inc. Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ.	Health Technology
Bayer HealthCare AG Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.	Health Technology